NewEdge Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39K | Hold |
100
| – | – | ﹤0.01% | 3581 |
|
|
2025
Q1 | $2.49K | Hold |
100
| – | – | ﹤0.01% | 3462 |
|
|
2024
Q4 | $1.88K | Hold |
100
| – | – | ﹤0.01% | 3461 |
|
|
2024
Q3 | $1.51K | Hold |
100
| – | – | ﹤0.01% | 3441 |
|
|
2024
Q2 | $2.86K | Hold |
100
| – | – | ﹤0.01% | 3264 |
|
|
2024
Q1 | $2.92K | Sell |
100
-187
| -65% | -$5.46K | ﹤0.01% | 3292 |
|
|
2023
Q4 | $9.68K | Hold |
287
| – | – | ﹤0.01% | 2862 |
|
|
2023
Q3 | $8.81K | Hold |
287
| – | – | ﹤0.01% | 2617 |
|
|
2023
Q2 | $11.5K | Buy |
287
+187
| +187% | +$7.49K | ﹤0.01% | 2556 |
|
|
2023
Q1 | $4.08K | Sell |
100
-4
| -4% | -$163 | ﹤0.01% | 2847 |
|
|
2022
Q4 | $4 | Buy |
+104
| New | +$4 | ﹤0.01% | 3854 |
|
|
2017
Q3 | – | Sell |
-158
| Closed | -$7.8K | – | 891 |
|
|
2017
Q2 | $7.8K | Buy |
+158
| New | +$7.8K | ﹤0.01% | 1042 |
|